Detalhe da pesquisa
1.
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
N Engl J Med
; 388(23): 2159-2170, 2023 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972022
2.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
N Engl J Med
; 388(23): 2145-2158, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972026
3.
Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer.
Cancer
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38288862
4.
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes.
Gynecol Oncol
; 184: 31-42, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277919
5.
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Gynecol Oncol
; 183: 103-114, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593674
6.
Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
Int J Gynecol Cancer
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38684343
7.
HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis.
Gynecol Oncol
; 172: 98-105, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003074
8.
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutation.
Gynecol Oncol
; 177: 132-141, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683549
9.
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.
Gynecol Oncol
; 177: 38-45, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634258
10.
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.
N Engl J Med
; 380(24): 2317-2326, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189035
11.
The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer.
BMC Cancer
; 22(1): 263, 2022 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279106
12.
Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomography.
Gynecol Oncol
; 166(1): 173-180, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537885
13.
The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignancies.
Gynecol Oncol
; 165(3): 486-492, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35370010
14.
HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy.
Gynecol Oncol
; 167(2): 289-294, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114027
15.
High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer.
Gynecol Oncol
; 167(3): 496-501, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180305
16.
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.
Gynecol Oncol
; 164(2): 428-436, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903380
17.
Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning.
Gynecol Oncol
; 166(1): 90-99, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35624045
18.
The Use of Targeted Agents in the Treatment of Gynecologic Cancers.
Curr Treat Options Oncol
; 23(1): 15-28, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167006
19.
Uterine carcinosarcomas: From pathology to practice.
Gynecol Oncol
; 162(1): 235-241, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34030871
20.
Text-message-based behavioral weight loss for endometrial cancer survivors with obesity: A randomized controlled trial.
Gynecol Oncol
; 162(3): 770-777, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140179